Odake S, Kam C M, Narasimhan L, Poe M, Blake J T, Krahenbuhl O, Tschopp J, Powers J C
School of Chemistry, Georgia Institute of Technology, Atlanta 30332.
Biochemistry. 1991 Feb 26;30(8):2217-27. doi: 10.1021/bi00222a027.
The active site structures of human Q31 granzyme A, murine granzymes (A, B, C, D, E, and F), and human granzymes (A, B, and 3) isolated from cytotoxic T lymphocytes (CTL) were studied with peptide thioester substrates, peptide chloromethyl ketone, and isocoumarin inhibitors. Human Q31, murine, and human granzyme A hydrolyzed Arg- or Lys-containing thioesters very efficiently with kcat/KM of 10(4)-10(5) M-1 s-1. Murine granzyme B was found to have Asp-ase activity and hydrolyzed Boc-Ala-Ala-Asp-SBzl with a kcat/KM value of 2.3 X 10(5) M-1 s-1. The rate was accelerated 1.4-fold when the 0.05 M NaCl in the assay was replaced with CaCl2. The preparation of granzyme B also had significant activity toward Boc-Ala-Ala-AA-SBzl substrates, where AA was Asn, Met, or Ser [kcat/KM = (4-5) X 10(4) M-1 s-1]. Murine granzymes C, D, and E did not hydrolyze any thioester substrate but contained minor contaminating activity toward Arg- or Lys-containing thioesters. Murine granzyme F had small activity toward Suc-Phe-Leu-Phe-SBzl, along with some contaminating trypsin-like activity. Human Q31 granzyme A, murine, and human granzyme A were inhibited quite efficiently by mechanism-based isocoumarin inhibitors substituted with basic groups (guanidino or isothiureidopropoxy). Although the general serine protease inhibitor 3,4-dichloroisocoumarin (DCI) inactivated these tryptases poorly, it was the best isocoumarin inhibitor for murine granzyme B (kobs/[I] = 3700-4200 M-1 s-1). Murine and human granzyme B were also inhibited by Boc-Ala-Ala-Asp-CH2Cl; however, the inhibition was less potent than that with DCI. DCI, 3-(3-amino-propoxy)-4-chloroisocoumarin, 4-chloro-3-(3-isothiureidopropoxy)isocoumarin, and 7-amino-4-chloro-3-(3-isothiureidopropoxy)isocoumarin inhibited Q31 cytotoxic T lymphocyte mediated lysis of human JY lymphoblasts (ED50 = 0.5-5.0 microM).
采用肽硫酯底物、肽氯甲基酮和异香豆素抑制剂,对从细胞毒性T淋巴细胞(CTL)中分离出的人Q31颗粒酶A、鼠颗粒酶(A、B、C、D、E和F)以及人颗粒酶(A、B和3)的活性位点结构进行了研究。人Q31、鼠和人颗粒酶A能非常有效地水解含精氨酸或赖氨酸的硫酯,催化常数与米氏常数的比值(kcat/KM)为10⁴ - 10⁵ M⁻¹ s⁻¹。发现鼠颗粒酶B具有天冬氨酸酶活性,能水解Boc - Ala - Ala - Asp - SBzl,其kcat/KM值为2.3×10⁵ M⁻¹ s⁻¹。当测定中0.05 M的氯化钠被氯化钙取代时,反应速率加快了1.4倍。颗粒酶B制剂对Boc - Ala - Ala - AA - SBzl底物(其中AA为天冬酰胺、甲硫氨酸或丝氨酸)也有显著活性[kcat/KM = (4 - 5)×10⁴ M⁻¹ s⁻¹]。鼠颗粒酶C、D和E不水解任何硫酯底物,但对含精氨酸或赖氨酸的硫酯有轻微的污染活性。鼠颗粒酶F对Suc - Phe - Leu - Phe - SBzl有微弱活性,同时还有一些类似胰蛋白酶的污染活性。人Q31颗粒酶A、鼠和人颗粒酶A能被带有碱性基团(胍基或异硫脲基丙氧基)的基于机制的异香豆素抑制剂非常有效地抑制。尽管一般的丝氨酸蛋白酶抑制剂3,4 - 二氯异香豆素(DCI)对这些类胰蛋白酶的灭活效果不佳,但它是鼠颗粒酶B的最佳异香豆素抑制剂(观测到的反应速率常数与抑制剂浓度的比值kobs/[I] = 3700 - 4200 M⁻¹ s⁻¹)。鼠和人颗粒酶B也能被Boc - Ala - Ala - Asp - CH₂Cl抑制;然而,这种抑制作用比DCI弱。DCI、3 - (3 - 氨基 - 丙氧基)-4 - 氯异香豆素、4 - 氯 - 3 - (3 - 异硫脲基丙氧基)异香豆素和7 - 氨基 - 4 - 氯 - 3 - (3 - 异硫脲基丙氧基)异香豆素抑制Q31细胞毒性T淋巴细胞介导的人JY淋巴母细胞裂解(半数有效浓度ED50 = 0.5 - 5.0 μM)。